<DOC>
	<DOCNO>NCT00540202</DOCNO>
	<brief_summary>We test hypothesis difference effectiveness oral quinine comparison artemether Lumefantrine treatment uncomplicated malaria child .</brief_summary>
	<brief_title>Effectiveness Oral Quinine Artemether-Lumefantrine Treatment Uncomplicated Malaria Ugandan Children</brief_title>
	<detailed_description>This study design open randomize effectiveness study assess parasitological clinical cure rate adherence oral quinine monotherapy comparison artemether-Lumefantrine . We also describe adverse event two drugs.The measurement include age , sex , weight , hemoglobin level day 0 , 7 , 14 28 , parasite density day 0 , 7 , 14 28 clinical examination finding . Adverse event also document</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Quinine</mesh_term>
	<criteria>1 . Aged 6 59 month age see assessment centre study period 2 . With fever define axillary temperature ≥37.5 °C history fever past 24 h 3 . With microscopically confirm monoinfection Plasmodium falciparum 4 . Able tolerate oral therapy , 5 . Whose parents/guardians provide write informed consent . 1 . Children history allergy quinine , artemetherLumefantrine milk . 2 . Evidence severe malaria . 3 . Residence 20km health clinic . 4 . Evidence significant concomitant febrile illness would require hospitalization chronic medical illness</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Effectiveness</keyword>
	<keyword>Oral quinine</keyword>
	<keyword>Coartem</keyword>
	<keyword>Uncomplicated malaria</keyword>
	<keyword>Children</keyword>
</DOC>